Nymox Pharmaceutical Stock Price (NASDAQ:NYMX)

Add to My Stocks
$3.92 $0.06 (1.51%) NYMX stock closing price Jul 25, 2017 (Closing)
Prev Close* : $3.98
Market Cap:
$200.79M
Day Low: $3.91
52 Week Low: $1.62
Open: $3.97
Volume: 90467
Day High: $4.05
52 Week High: $5.79
Dividend:
N/A

Latest Stock Market News

Latest Articles

Nymox Pharmaceutical News - From Partners

NYMX Stockcharts

View NYMX PE ratio, PS ratio stocks charts and compare with peers.
NYMX Chart
Note: Compare Nymox Pharmaceutical stock price history with the index and industry peers.

Nymox Pharmaceutical Valuation

PS ratio (
price to sales ratio
)
608.83

Nymox Pharmaceutical Financial Ratios

Asset Turnover
0.17
Receivables Turnover
4.71

NYMX Industry Peers

Company Price Change (%)
Zymeworks Inc (ZYME)7.290.18 (2.41%)
Kura Oncology (KURA)9.30.1 (1.06%)
Cascade Corp (CASC)3.990.06 (1.48%)
Spring Bank Pharma (SBPH)14.070.12 (0.86%)
Baxalta (BXLT)46.020.18 (0.39%)
Regeneron Pharma (REGN)513.457.77 (1.49%)
Alexion Pharma (ALXN)129.351.39 (1.06%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Compugen (CGEN)4.050.65 (19.12%)
Idera Pharma (IDRA)2.060.14 (7.29%)
Merrimack Pharma (MACK)1.360.05 (3.82%)
PDL BioPharma (PDLI)2.460.08 (3.36%)
Horizon Pharma (HZNP)13.480.32 (2.43%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Acorda Therapeutics (ACOR)22.850.45 (2.01%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017
CompanyPriceChange (%)
Novavax (NVAX)1.10.41 (27.15%)
Dynavax Technologies (DVAX)9.90.75 (7.04%)
Vital Therapies (VTL)2.650.15 (5.36%)
EXACT Sciences (EXAS)37.332.11 (5.35%)
China Biologic Products (CBPO)98.325.05 (4.89%)
Epizyme (EPZM)12.650.65 (4.89%)
Trevena (TRVN)2.820.14 (4.73%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017

Nymox Pharmaceutical Financial Statements

income statement20162015201420132012
Net Sales Or Revenues0.28M2.76M2.94M3.35M3.07M
Net Income-13.1M-17.88M-4.59M-4.9M-7.62M
Total Operating Expense12.97M20.25M7.49M7.74M10.41M
view Nymox Pharmaceutical Corporation income statement
balance sheet20162015201420132012
Total Assets2.05M0.71M1.42M0.96M1.75M
Total Liabilities2.69M3.46M5.6M7.02M9.19M
Shareholders Equity-0.64M-2.75M-4.18M-6.05M-7.44M
view Nymox Pharmaceutical Corporation balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-0.58M-1.74M-2.3M-2.12M-2.64M
Net Cash From (Used By) Operating Activities-4.5M-3.75M-5.51M-6.71M-8.3M
Increase (Decrease) In Prop Plant And Equipment----0.01M-
view Nymox Pharmaceutical Corporation cashflow statement

Nymox Pharmaceutical Stock Message Board

Nymox Pharmaceutical stock price ended the last trading day at 3.92. The total market value as denoted by 200.79M for Nymox Pharmaceutical, is the market value of the company's outstanding shares. Nymox Pharmaceutical valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Nymox Pharmaceutical stock price and Nymox Pharmaceutical share price mean the same thing. The volume of shares traded stood at 90467 on the last trading day, as is evident from Nymox Pharmaceutical stock chart, and NYMX stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Nymox Pharmaceutical stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.